<?xml version="1.0" encoding="UTF-8"?>
<p>A total of 448 healthy bone marrow donors (HD), as well as 398 HIV-1 infected patients, comprising 55 AIDS patients, 213 typical progressors (TP) and 130 LTNP, were included in the study. The uninfected individuals were healthy Spanish donors from the Blood Transfusion Centre of the Community of Madrid, Spain, and are representative of the Spanish population [
 <xref rid="pone.0220459.ref026" ref-type="bibr">26</xref>]. All HIV-1 infected patients belonged to different cohorts of patients with samples stored at the HIV BioBank (Gregorio Marañón University Hospital, Madrid, Spain), which is integrated in the Spanish AIDS research network (RIS) [
 <xref rid="pone.0220459.ref027" ref-type="bibr">27</xref>] All the samples were collected from 2004 to 2007. CoRIS, the RIS cohort of adults with HIV infection, was launched in 2004 [
 <xref rid="pone.0220459.ref028" ref-type="bibr">28</xref>]. CoRIS is an open multicenter cohort of patients that are over 13 years of age and newly diagnosed with HIV infection in the participating hospital or treatment center they attend for the first time, and that are naïve to antiretroviral treatment. This study was reviewed and approved by the institutional Ethics committee for research and clinical trials" (CEIC) from Instituto de Salud Carlos III. All patients signed and informed consent to include their blood samples for scientific research including genetic studies in the Biobank of the Spanish AIDS Research Network. The information is subject to internal quality controls; once every 2 years, information on 10% of the cohort is audited by an external agency.
</p>
